PTH and hyperphosphatemia: The p.Asn502His variant showed a reduction in transactivation and it was found in the heterozygous state in one patient diagnosed at 5 days of age, presenting with hypocalcemia, hyperphosphatemia, hypomagnesemia, low 25-OH vitamin D levels and normal serum intact PTH levels.